The translational relevance of these in vitro findings rests on data that SIRT3-deficient mice exhibited a more severe AKI compared to their WT littermates, and did not respond to UC-MSC treatment, thus underlying the essential contribution of SIRT3, a key target of cell therapy, in the process of tubular repair. Here, SIRT3 is linked to acute kidney injury.